30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

McCulloch Kevin

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 24% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
McCulloch Kevin's trades of Xeris Biopharma Holdings Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-09 2026-01-08
PlS Planned sale
25,444 +31.0%
225.64
US$4,055,800 		25,444 +31.0% 225.64 US$4,055,800
2026-01-08 2026-01-08
PrS Proposed sale
89,542
434.72
US$2,947,398 		89,542 434.72 US$2,947,398
2025-06-16 2025-06-13
B Purchase
83,208 -44.6%
91.24
US$3,506,288 		83,208 -44.6% 91.24 US$3,506,288